GLP-1 receptor agonists emerge as potential game-changers in psychiatric treatment, targeting mental disorders and improving cognitive function
For the majority of FPV drones, flight times are in the region of 3-6 minutes, so clearly we are putting large loads on our batteries
Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5
AP: conception of the idea, preparation of figures, manuscript writing and editing, supervised and directed the overall project